News Headlines Article

Drug pricing, cancer stem cells and the BIO convention — all on our BioFlash podcast
San Francisco Business Times

Paul Hastings has ideas — and the chairman and CEO of OncoMed Pharmaceuticals Inc. isn’t afraid to share them. That’s why we thought of him as the first guest for our new BioFlash podcast.

The biweekly podcast — you can listen to it here— features the issues and personalities driving the Bay Area life sciences industry. With drug pricing, innovation and gender diversity continuing to draw headlines, we’ll talk to those who are driving the discussion.